MedPath

Oral hypoglycaemic activity of Pleurotus mushrooms on diabetic subjects

Not Applicable
Recruiting
Conditions
Diabetes mellitus
Registration Number
SLCTR/2013/021
Lead Sponsor
niversity of Sri Jayewardenepura
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1.Type 2 diabetic patients
2.On diet control only
3.Ability to read and understand Sinhala and English

Exclusion Criteria

1.Type 1 diabetics
2.Pregnancy /breastfeeding
3.Patients on any oral hypoglycaemic medication
4.Patients on insulin
5.Patients on herbal medications known to have an effect on blood glucose

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose<br> [Prior to administration of the mushroom suspension<br>]<br>Post glucose loaded (OGTT) blood glucose [2 hours after glucose load.]<br>Serum insulin levels (using ELIZA kits) [2 hours after glucose load.]<br>
Secondary Outcome Measures
NameTimeMethod
Change in liver function : serum alanine amino transferase, aspartate amino transferase, alkaline phosphatase, gamma glutamyl transpeptidase <br><br> [At base line and at the end of 4 weeks<br><br>]<br>Change in renal function : serum creatinine [At baseline and at the end of 4 weeks]<br>
© Copyright 2025. All Rights Reserved by MedPath